Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yuki Oiso"'
Publikováno v:
Pharmaceutics, Vol 12, Iss 3, p 200 (2020)
When developing inhaled medicines for respiratory diseases, such as chronic obstructive pulmonary disease, drugs need to be administered by pulmonary delivery to animals in non-clinical tests. Common methods require application of pressure during adm
Externí odkaz:
https://doaj.org/article/d75256008b6a4a8d8b04ef899a35eda7
Publikováno v:
Pharmaceutics, Vol 12, Iss 3, p 200 (2020)
Pharmaceutics
Volume 12
Issue 3
Pharmaceutics
Volume 12
Issue 3
When developing inhaled medicines for respiratory diseases, such as chronic obstructive pulmonary disease, drugs need to be administered by pulmonary delivery to animals in non-clinical tests. Common methods require application of pressure during adm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19e20d9bbde85bf955c207a53d5dcb4a
https://www.mdpi.com/1999-4923/12/3/200
https://www.mdpi.com/1999-4923/12/3/200
Autor:
Mai Hirokawa, Tomomi Akita, Hitomi Sakai, Michiko Horiguchi, Isao Tachibana, Harumi Kumagai, Yoshito Takeda, Yuki Oiso, Norikazu Maeda, Chikamasa Yamashita, Chihiro Ozawa
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 361:501-505
Chronic obstructive pulmonary disease (COPD) is an intractable pulmonary disease that causes widespread and irreversible alveolar collapse. Although COPD occurs worldwide, only symptomatic therapy is currently available. Our objective is the developm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef2afc60ec71d1324edb4b77b2e43245
https://doi.org/10.1124/jpet.117.240515
https://doi.org/10.1124/jpet.117.240515
Autor:
Tomoki Motomura, Chikamasa Yamashita, Michiko Horiguchi, Tomomi Akita, Kaori Abe, Yuki Oiso, Chihiro Ozawa
Publikováno v:
Biological & Pharmaceutical Bulletin. 39:778-785
Pulmonary emphysema is a disease in which lung alveoli are irreversibly damaged, thus compromising lung function. Our previous study revealed that all-trans-retinoic acid (ATRA) induces the differentiation of human lung alveolar epithelial type 2 pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5015f3004fd64f93c40fdff9c3bdd283
https://doi.org/10.1248/bpb.b15-00909
https://doi.org/10.1248/bpb.b15-00909
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 213
Chronic obstructive pulmonary disease (COPD) is an intractable pulmonary disease, causing widespread and irreversible alveoli collapse. The discovery of a low-molecular-weight compound that induces regeneration of pulmonary alveoli is of utmost urgen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f7360553bf3b3193a13332feef1e310
https://pubmed.ncbi.nlm.nih.gov/26160307
https://pubmed.ncbi.nlm.nih.gov/26160307